
Apellis Pharmaceuticals
Data breach claim reported November 17, 2026
| Data Breach Report | |||
|---|---|---|---|
| Victim | apellis.com | ||
| Claimed By | Vortex | ||
| Date Discovered | Nov 17, 2026 | ||
| Description | Apellis Pharmaceuticals is a biopharmaceutical company based in the USA (Massachusetts), developing therapies that target C3 to control complement, with programs in ophthalmology, nephrology, hematology, and neurology. | ||
| Leak Size | 307.64GB |
Breach claims on this page are published by threat actors and haven't been verified by Breachsense.
Credential Exposure for apellis.com
We've indexed 42 @apellis.com accounts from external breaches.
Last checked Nov 17, 2026
| @apellis.com addresses from external breaches | |
|---|---|
| Combo lists | 27 accounts · most recent Nov 12, 2026 |
| Third-party breaches | 18 accounts · across 14 breaches · 15 with a plaintext password · most recent Aug 18, 2024 |
None of this is necessarily connected to the ransomware attack above.
Is your organization next?
Check if your company's credentials have been exposed in this or other data breaches.
Continuous dark web monitoring alerts you when we find leaked credentials or session tokens for your company.